Hakutulokset - H. Barton Grossman
- Näytetään 1 - 20 yhteensä 49 tuloksesta
- Siirry seuraavalle sivulle
-
1
Bladder carcinoma in patients age 40 years or younger Tekijä Julian Wan, H. Barton Grossman
Julkaistu 1989Artigo -
2
-
3
-
4
-
5
-
6
18F-2-deoxy-2-fluoro-D-glucose uptake into human tumor xenografts. Feasibility studies for cancer imaging with positron-emission tomography Tekijä Richard L. Wahl, Gary D. Hutchins, Donald J. Buchsbaum, Monica Liebert, H. Barton Grossman, Susan J. Fisher
Julkaistu 1991Artigo -
7
Modulation of DNA damage/DNA repair capacity by XPC polymorphisms Tekijä Yimin Zhu, Hushan Yang, Qin Chen, Jie Lin, H. Barton Grossman, Colin P. Dinney, Xifeng Wu, Jian Gu
Julkaistu 2007Artigo -
8
-
9
A phase 2 clinical trial of sequential neoadjuvant chemotherapy with ifosfamide, doxorubicin, and gemcitabine followed by cisplatin, gemcitabine, and ifosfamide in locally advanced... Tekijä Arlene O. Siefker‐Radtke, Colin P. Dinney, Yu Shen, Dallas Williams, Ashish M. Kamat, H. Barton Grossman, Randall E. Millikan
Julkaistu 2012Artigo -
10
Role of Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand in Interferon-Induced Apoptosis in Human Bladder Cancer Cells Tekijä Angela Papageorgiou, Laura M. Lashinger, Randall E. Millikan, H. Barton Grossman, William Benedict, Colin P. Dinney, David J. McConkey
Julkaistu 2004Artigo -
11
High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk Tekijä Min Chen, A. M. Kamat, Monica L. Huang, H. Barton Grossman, Colin P. Dinney, Seth P. Lerner, Xifeng Wu, Jian Gu
Julkaistu 2007Artigo -
12
-
13
-
14
-
15
-
16
Ability of Clinical Grade to Predict Final Pathologic Stage in Upper Urinary Tract Transitional Cell Carcinoma: Implications for Therapy Tekijä Gordon Brown, Surena F. Matin, J. Erik Busby, Colin P. Dinney, H. Barton Grossman, Curtis A. Pettaway, Mark F. Munsell, Ashish M. Kamat
Julkaistu 2007Artigo -
17
P0 Stage at Radical Cystectomy for Bladder Cancer is Associated with Improved Outcome Independent of Traditional Clinical Risk Factors Tekijä Wassim Kassouf, Philippe E. Spiess, Gordon Brown, Mark F. Munsell, H. Barton Grossman, Arlene O. Siefker‐Radtke, Colin P. Dinney, Ashish M. Kamat
Julkaistu 2007Artigo -
18
Phase II Clinical Trial of Neoadjuvant Alternating Doublet Chemotherapy With Ifosfamide/Doxorubicin and Etoposide/Cisplatin in Small-Cell Urothelial Cancer Tekijä Arlene O. Siefker‐Radtke, Ashish M. Kamat, H. Barton Grossman, Dallas Williams, Wei Qiao, Peter F. Thall, Colin P. Dinney, Randall E. Millikan
Julkaistu 2009Artigo -
19
Hexaminolevulinate Guided Fluorescence Cystoscopy Reduces Recurrence in Patients With Nonmuscle Invasive Bladder Cancer Tekijä Arnulf Stenzl, Maximilian Burger, Yves Fradet, Lance A. Mynderse, Mark S. Soloway, J. Alfred Witjes, M. Kriegmair, Alexander Karl, Yu Shen, H. Barton Grossman
Julkaistu 2010Artigo -
20
Työkalut:
Liittyvät aiheet
Cancer
Bladder cancer
Medicine
Internal medicine
Biology
Oncology
Genetics
Surgery
Gene
Urology
Chemotherapy
Cystectomy
Cancer research
Genotype
Single-nucleotide polymorphism
Paleontology
Stage (stratigraphy)
Urinary system
Allele
Odds ratio
Pathology
Proportional hazards model
Breast cancer
Carcinoma
Confidence interval
Gastroenterology
Neoadjuvant therapy
Physics
Biochemistry
Bioinformatics